Vasculox
Saint Louis, US · Delaware corporation · 1 known investors
Founders & leadership
KL
Kalthleen L. BeckmannExecutive
RW
Robert W. KarrExecutive
PM
Pamela ManningExecutive
WF
William FrazierNamed on SEC filing
Board
JM
John McKearnBoard director
CB
Charles BoltenBoard director
BS
Bobby Sandage, Jr.Board director
DB
Dan BroderickBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$34.4M disclosed across 2 rounds · 2014–2015
▶$33.2MraisedAug 2016 · 12 investors · PharmaceuticalsRule 506(b)
▶$33.2MraisedAug 2016 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- John McKearnDirector
- John DonovanExecutive Officer, Director
- James StutzExecutive Officer
- Carole L. NuechterleinDirector
- Pamela T. ManningExecutive Officer
- Robert W. KarrExecutive Officer
- Jill CarrollDirector
- Peter MoldtDirector
- Offering amount
- $86.3M
- Amount sold
- $33.2M
- First sale
- Jun 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedFeb 2015 · 3 investors · PharmaceuticalsRule 506(b)
▶$1.3MraisedFeb 2015 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Kalthleen L. BeckmannExecutive Officer
- Charles BoltenDirector
- Bobby Sandage, Jr.Director
- William FrazierDirector
- Robert W. KarrExecutive Officer, Director
- Pamela ManningExecutive Officer
- John McKearnDirector
- Dan BroderickDirector
- Offering amount
- $2.8M
- Amount sold
- $1.3M
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Vasculox's investors?
- Vasculox's investors include RiverVest Venture Partners.
- How much funding has Vasculox raised?
- Vasculox has disclosed $34.4M raised across 2 rounds.
- Where is Vasculox headquartered?
- Vasculox is headquartered in Saint Louis, US.